Congress Passes Legislation To Provide Funding For Autism Research, Treatment
Main Category: AutismArticle Date: 12 Dec 2006 - 11:00 PDT
| Patient / Public: | ![]() |
4.75 (4 votes) |
| Healthcare Prof: | ![]() |
5 (3 votes) |
The Senate on Thursday by voice vote approved a bill (S 843), sponsored by Sen. Rick Santorum (R-Pa.), that would authorize $945 million over five years for autism research, screenings, treatment and education, CQ Today reports. The Senate first passed the legislation by voice vote in August but had to vote a second time to approve revisions made by the House (George, CQ Today, 12/7). The House on Wednesday by voice vote passed the bill. The revisions, proposed by House Energy and Commerce Committee Chair Joe Barton (R-Texas), increased funds for the legislation from $870 million to $945 million. In addition, the revisions eliminated a provision that would have required the establishment of new NIH "centers of excellence" for autism research or language to mandate funding levels for specific research initiatives (George, CQ Today, 12/6). Marguerite Kirst Colston, communications director for the Autism Society of America, said, "We think it's a really incredible first step for lawmakers" (CQ Today, 12/7).
Bill Passed To Limit Sales of Cold-Medication Ingredient
The House on Wednesday also passed a bill (HR 5280) designed to limit unapproved sales of bulk and powdered dextromethorphan, a cold medication ingredient that can be abused, CQ Today reports. DXM, an ingredient that is sold in over-the-counter cough and cold medicine or over the internet in powdered form, has been used by teenagers who ingest the syrup or mix the substance with alcohol or illegal drugs. The bill, which was sponsored by Rep. Fred Upton (R-Mich.), would limit bulk purchases of the ingredient. The bill also would restrict the sale and distribution of unfinished ingredients such as DXM to registered drug producers. The bill passed by voice vote under suspension of the rules. FDA has said that DXM can cause "death as well as other serious adverse events such as brain damage, seizure, loss of consciousness and irregular heart beat." Upton in a statement said, "Our kids are playing a game of Russian roulette each time they get high off of DXM. Sooner or later, someone dies" (Stern, CQ Today, 12/6).
House Approves Respite Care Bill
In addition, the House on Wednesday approved the Lifespan Respite Care Act, a bill sponsored by Rep. Mike Ferguson (R-N.J.) that would provide $289 million over five years for states to train volunteers and provide other services to family caregivers, the AP/Asbury Park Press reports. HHS would distribute the funds to states, which would award grants. Ferguson said, "Today's action by this House represents an important victory nationwide to family caregivers. Your selfless sacrifice is appreciated and help is on the way" (AP/Asbury Park Press, 12/7).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our autism section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/58534.php>
APA
http://www.medicalnewstoday.com/releases/58534.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




